10-58385557-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003201.3(TFAM):c.10C>G(p.Leu4Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000639 in 1,565,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003201.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFAM | NM_003201.3 | c.10C>G | p.Leu4Val | missense_variant | 1/7 | ENST00000487519.6 | NP_003192.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFAM | ENST00000487519.6 | c.10C>G | p.Leu4Val | missense_variant | 1/7 | 1 | NM_003201.3 | ENSP00000420588.1 | ||
TFAM | ENST00000373895.7 | c.10C>G | p.Leu4Val | missense_variant | 1/6 | 2 | ENSP00000363002.3 | |||
TFAM | ENST00000373899.3 | n.213C>G | non_coding_transcript_exon_variant | 1/8 | 2 | |||||
TFAM | ENST00000395377.2 | c.-48C>G | upstream_gene_variant | 2 | ENSP00000378776.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000354 AC: 5AN: 1413618Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 698630
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.10C>G (p.L4V) alteration is located in exon 1 (coding exon 1) of the TFAM gene. This alteration results from a C to G substitution at nucleotide position 10, causing the leucine (L) at amino acid position 4 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 27, 2023 | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 4 of the TFAM protein (p.Leu4Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TFAM-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at